Literature DB >> 11287822

Pathogenesis and pathology of COPD.

G Turato1, R Zuin, M Saetta.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation. Since flow is the result of a driving pressure that promotes flow and of an opposing resistance that contradicts it, the reduction in flow observed in COPD has two main components: increased resistance, which is due to airway obstruction, and a loss of the elastic recoil pressure of the lung, which is due to parenchymal destruction. Although it has long been known that the major site of increased resistance in COPD is the peripheral airways, recent studies have shown that central airways are involved in the disease as well. The purpose of this review is to describe the major structural and cellular changes present in peripheral airways, central airways and lung parenchyma of patients with COPD, and to underline the possible mechanisms contributing to airflow limitation in these subjects. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11287822     DOI: 10.1159/000050478

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  19 in total

1.  Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.

Authors:  Xinying Li; Noriel Mariano; James J Rahal; Carl M Urban; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 2.  Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management.

Authors:  Julie E Zeskind; Marc E Lenburg; Avrum Spira
Journal:  Proc Am Thorac Soc       Date:  2008-12-01

3.  Automated quantification of lung structures from optical coherence tomography images.

Authors:  Alex M Pagnozzi; Rodney W Kirk; Brendan F Kennedy; David D Sampson; Robert A McLaughlin
Journal:  Biomed Opt Express       Date:  2013-10-09       Impact factor: 3.732

Review 4.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

5.  Association between markers of emphysema and more severe chronic obstructive pulmonary disease.

Authors:  P Boschetto; S Quintavalle; E Zeni; S Leprotti; A Potena; L Ballerin; A Papi; G Palladini; M Luisetti; L Annovazzi; P Iadarola; E De Rosa; L M Fabbri; C E Mapp
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

6.  CTLA-4 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease.

Authors:  Lijing Deng; Haixia Zhou; Jing Yang; Jun Xiao; Bo Wang; Lan Wang; Xuemei Ou; Yulin Feng
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

7.  An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.

Authors:  Sandra Grumelli; David B Corry; Li-Zhen Song; Ling Song; Linda Green; Joseph Huh; Joan Hacken; Rafael Espada; Remzi Bag; Dorothy E Lewis; Farrah Kheradmand
Journal:  PLoS Med       Date:  2004-10-19       Impact factor: 11.069

8.  Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases.

Authors:  J Ngo; M Matsuyama; C Kim; I Poventud-Fuentes; A Bates; S L Siedlak; H-G Lee; Y Q Doughman; M Watanabe; A Liner; B Hoit; N Voelkel; S Gerson; P Hasty; S Matsuyama
Journal:  Cell Death Dis       Date:  2015-03-26       Impact factor: 8.469

9.  A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients.

Authors:  Jiandong Wu; Craig Hillier; Paul Komenda; Ricardo Lobato de Faria; David Levin; Michael Zhang; Francis Lin
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 10.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.